Decreased SIRT3 levels and activity have been demonstrated in pulmonary artery smooth muscle cells (PASMC) of PAH human patients and MCT-induced PH rats [33], as well as in lung tissues and pulmonary artery adventitial fibroblasts of PH bovine model and human patients [32]. Here, SIRT3 is linked to pulmonary arterial hypertension.